Breakthrough in Longevity: New Bio-Tech Treatment Shows 30% Success Rate

Phase Status: Clinical Trial III

Success Rate: +32.5% vs 2025

Researchers in Switzerland have unveiled a new gene-editing technique that aims to reverse cellular aging. The global health sector is calling this the "Discovery of the Decade."